GAD1 and type 2 diabetes mellitus: In a smaller Pittsburgh cohort of the Cardiovascular Health Study (2000), of patients newly diagnosed with T2DM (n = 196), 12% were positive for autoantibodies (GAD, IA-2A) [80].